Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8835 | 1144 | 29.4 | 46% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEFIRACETAM | Author keyword | 65 | 81% | 3% | 39 |
2 | DM 9384 | Author keyword | 48 | 100% | 1% | 17 |
3 | ANIRACETAM | Author keyword | 39 | 55% | 4% | 49 |
4 | OXIRACETAM | Author keyword | 38 | 70% | 3% | 32 |
5 | CAS 77191 36 7 | Author keyword | 37 | 100% | 1% | 14 |
6 | NOOTROPICS | Author keyword | 33 | 48% | 4% | 51 |
7 | PIRACETAM | Author keyword | 29 | 33% | 6% | 74 |
8 | CNS SUPPORTING | Address | 27 | 92% | 1% | 11 |
9 | NEFIRACETAM DM 9384 | Author keyword | 18 | 89% | 1% | 8 |
10 | SUNIFIRAM | Author keyword | 18 | 89% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEFIRACETAM | 65 | 81% | 3% | 39 | Search NEFIRACETAM | Search NEFIRACETAM |
2 | DM 9384 | 48 | 100% | 1% | 17 | Search DM+9384 | Search DM+9384 |
3 | ANIRACETAM | 39 | 55% | 4% | 49 | Search ANIRACETAM | Search ANIRACETAM |
4 | OXIRACETAM | 38 | 70% | 3% | 32 | Search OXIRACETAM | Search OXIRACETAM |
5 | CAS 77191 36 7 | 37 | 100% | 1% | 14 | Search CAS+77191+36+7 | Search CAS+77191+36+7 |
6 | NOOTROPICS | 33 | 48% | 4% | 51 | Search NOOTROPICS | Search NOOTROPICS |
7 | PIRACETAM | 29 | 33% | 6% | 74 | Search PIRACETAM | Search PIRACETAM |
8 | NEFIRACETAM DM 9384 | 18 | 89% | 1% | 8 | Search NEFIRACETAM+DM+9384 | Search NEFIRACETAM+DM+9384 |
9 | SUNIFIRAM | 18 | 89% | 1% | 8 | Search SUNIFIRAM | Search SUNIFIRAM |
10 | MOUSE PASSIVE AVOIDANCE TEST | 8 | 100% | 0% | 5 | Search MOUSE+PASSIVE+AVOIDANCE+TEST | Search MOUSE+PASSIVE+AVOIDANCE+TEST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DM 9384 | 94 | 89% | 4% | 42 |
2 | OXIRACETAM | 26 | 64% | 2% | 25 |
3 | PIRACETAM | 23 | 32% | 5% | 61 |
4 | NOOTROPIC DRUGS | 22 | 52% | 3% | 30 |
5 | ANIRACETAM | 15 | 35% | 3% | 36 |
6 | ANTIHYPOXIC DRUG | 13 | 80% | 1% | 8 |
7 | R 58 735 | 13 | 80% | 1% | 8 |
8 | NOOTROPIC DRUG OXIRACETAM | 12 | 86% | 1% | 6 |
9 | NOOTROPICS | 11 | 56% | 1% | 14 |
10 | PIRACETAM LIKE NOOTROPICS | 11 | 100% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
PIRACETAM AND OTHER STRUCTURALLY RELATED NOOTROPICS | 1994 | 186 | 214 | 70% |
Piracetam: A review of pharmacological properties and clinical uses | 2005 | 69 | 59 | 56% |
Piracetam for acute ischaemic stroke | 2012 | 2 | 6 | 100% |
Piracetam and Piracetam-Like Drugs From Basic Science to Novel Clinical Applications to CNS Disorders | 2010 | 50 | 112 | 30% |
TAKING STOCK OF COGNITION ENHANCERS | 1991 | 104 | 28 | 29% |
Pharmacological properties of piracetam - Rationale for use in stroke patients | 1998 | 12 | 36 | 86% |
RECENT DEVELOPMENTS IN 2-PYRROLIDINONE-CONTAINING NOOTROPICS | 1989 | 33 | 60 | 82% |
ANIRACETAM - AN OVERVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND A REVIEW OF ITS THERAPEUTIC POTENTIAL IN SENILE COGNITIVE DISORDERS | 1994 | 30 | 56 | 66% |
Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs | 2002 | 44 | 85 | 41% |
INTERDISCIPLINARY APPROACH OF VESTIBULAR SYSTEM IMPAIRMENT | 2011 | 2 | 8 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CNS SUPPORTING | 27 | 92% | 1.0% | 11 |
2 | SUPPORTING | 1 | 38% | 0.3% | 3 |
3 | DESIGN SYNTH STUDY BIOLOGICALLY ACT HETEROC | 1 | 50% | 0.2% | 2 |
4 | TOKYO DEV | 1 | 27% | 0.3% | 4 |
5 | NEUROSCI COGNIT MEMORY | 1 | 40% | 0.2% | 2 |
6 | SECT BRAIN BEHAV | 1 | 40% | 0.2% | 2 |
7 | UNIDAD MULTIDISCIPLINARIA INVEST EXPT | 1 | 40% | 0.2% | 2 |
8 | BIOL EXPTL NEUROBIOL MONDINO TOR VERGATA | 1 | 50% | 0.1% | 1 |
9 | MED 2 NEUROL | 1 | 50% | 0.1% | 1 |
10 | NEUROBIOL TAURAT FONCTIONNELLES | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189058 | VINPOCETINE//VA 045//CAS 42971 09 5 |
2 | 0.0000187389 | NOOPEPT//CYCLOPROLYLGLYCINE//GVS 111 |
3 | 0.0000185116 | BIFEMELANE HYDROCHLORIDE//BIFEMELANE//INDELOXAZINE HYDROCHLORIDE |
4 | 0.0000145185 | NAFTIDROFURYL//NEBRACETAM//MICROSPHERE EMBOLISM |
5 | 0.0000125617 | TACRINE//TETRAHYDROAMINOACRIDINE//METRIFONATE |
6 | 0.0000111449 | TACTIVIN//AMIRIDIN//CADDIES |
7 | 0.0000104212 | DCP LA//ALPHA 7 ACH RECEPTOR//ALPHA 7 ACETYLCHOLINE RECEPTOR |
8 | 0.0000101818 | TELE STEREO EEG//ELECTROPHARMACOGRAM//CATEEM |
9 | 0.0000099541 | CAS 17479 19 5//DECMER INTENS//CAS 14271 05 7 |
10 | 0.0000082485 | BLOOD NOW//OBESITY INDEX//BIOX DISCIPLINARY |